Related Experiment Video
Updated: Feb 26, 2026

07:27
Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
253
Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study
Adil Ayub1, Sadiq S Rehmani1, Adnan M Al-Ayoubi1
1Department of Thoracic Surgery, Icahn School of Medicine, Mount Sinai Health System, New York, New York.
The Annals of Thoracic Surgery
|July 16, 2017
Summary
Sublobar resection for a second lung cancer after pneumonectomy is feasible in select patients with early-stage, small tumors. Despite significant mortality, favorable survival rates may justify this procedure on a single lung.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Pulmonary resection for a second lung cancer post-pneumonectomy is considered high-risk.
- This study investigates treatment and survival in such patients.
Purpose of the Study:
- To analyze treatment patterns and survival outcomes for patients undergoing pulmonary resection after a pneumonectomy for lung cancer.
- To identify factors influencing surgical resection and compare survival between different resection types.
Main Methods:
- Utilized the Surveillance, Epidemiology, and End Results (SEER) database (1988-2012).
- Identified patients with pneumonectomy followed by contralateral non-small cell lung cancer (NSCLC).
- Employed multivariate logistic regression and Kaplan-Meier survival analysis.
Main Results:
- 3.0% of 13,370 pneumonectomy patients developed subsequent contralateral NSCLC; 42% met selection criteria.
- Surgical resection (37.1%) was more common for stage I/II disease and tumors ≤2 cm.
- Sublobar resection showed higher median overall survival (42 months) than lobectomy (18 months).
- 1-year and 3-year survival rates after resection were 79% and 54%, respectively.
Conclusions:
- Sublobar resection is a viable option for selected patients with small (≤2 cm), early-stage (I/II) contralateral NSCLC after pneumonectomy.
- While perioperative mortality is notable, favorable long-term survival justifies considering this procedure on a single lung.
Related Concept Videos
Pneumothorax-II
1.2K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
1.2K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
553
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
553

